TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 1 | 1 | 4 | 2 | -5 | -7 | -1 |
| P | %wins | 100 | 100 | 100 | 100 | 0 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/15/21 17:15 | 12/13/21 | SQZ | Sqz Biotechnologies Co | DE | Health | BioPrd | Biological Products, (No Diag | Schulman Amy W | MA | DT | P | 40 | 10.91 | 0 | 4 | 0 | 3,196 | I | |||||||||||||||
11/3/20 20:00 | 11/3/20 | SQZ | Sqz Biotechnologies Co | DE | Health | BioPrd | Biological Products, (No Diag | Schulman Amy W | MA | DT | P.d | 4,000 | 16.00 | 0 | 250 | 9 | 3,016 | M | |||||||||||||||
4/10/19 16:13 | 4/8/19 | CYCN | Cyclerion Therapeutics, Inc. | MA | Health | Drug | Pharmaceutical Preparations | Schulman Amy W | MA | D | P | 10,018 | 16.00 | 0 | 626 | 999% | 634 | I | |||||||||||||||
2/8/13 16:23 | 2/6/13 | ZTS | Zoetis Inc. | Health | Drug | Pharmaceutical Preparations | Schulman Amy W | NJ | D | P | 130 | 26.00 | 33 | 5 | New | 5 | D | 3 | 1 | 1 | 4 | 2 | -5 | -7 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |